Top Markets
#1 Threshold Network Threshold Network +65.04%
#2 TENDIES TENDIES +64.30%
#3 Cash Cat Cash Cat +22.24%
#4 OSK OSK +15.86%
#5 Magma Finance Magma Finance +13.64%
#6 Ape and Pepe Ape and Pepe +13.59%
#7 Asteroid Shiba Asteroid Shiba +13.00%
#8 Falcon Finance Falcon Finance +12.81%
#9 Kite Kite +12.56%
#10 龙虾 (Lobster) 龙虾 (Lobster) +11.22%
Coin of the day
Threshold Network Threshold Network
Settings
Language
ENGLISH
Currency
USD
Theme
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rank in Stocks #17261
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Share Price
$0.8502
Last synced: 2026-09-01
Market Cap
$250.47M
Change (1 day)
-10.96%
Change (1 year)
-17.46%
Country
US
Trade Invivyd, Inc. (IVVD)

Category

Healthcare
Stock price history for Invivyd, Inc. (IVVD)
Highest end of day price: $0.85 on 2026-09-01

Lowest end of day price: $27.68 on 2021-08-01
Stock price history of Invivyd, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -37.29%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.15 36.70%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 45.33%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $153.87 536.09%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $757.71 8.20%
CH